Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02326363 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Recovery in Veterans

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
204
Enrollment target

NCT02326363: Completed NA study, sponsored by VA Office of Research and Development.

NCT02326363 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 204 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02326363, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

This study will provide important information concerning the used of mindfulness-based relapse prevention (MBRP) as a continuing care strategy for Veterans who have completed primary treatment for a SUD. Most research is focused on the acute care of SUDs, but the risk of relapse to substance use is highest during the period immediately following treatment and attention to continuing care is critical. If this trial demonstrates that MBRP promotes sustained abstinence and improved functional outcomes, this will provide a valuable treatment to facilitate rehabilitation and recovery for Veterans with SUDs.

Primary Outcome

The TLFB will be used to obtain retrospective self-report of alcohol and illicit drug (e.g., cocaine, marijuana, stimulants, sedatives, opioids) use using calendar and memory prompts to stimulate recall. The TLFB yields consistently high test-retest correlations and correlates well with other self-reports and collateral reports. Quantity and frequency assessments as well as time-to-event measures can be obtained. Drug/alcohol use in treatment up to 8 weeks will be assessed.

Interventions

  • BEHAVIORAL Mindfulness Based Relapse Prevention (MBRP)
  • BEHAVIORAL Twelve-Step Facilitation Intervention (TSF)

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2015-03-16
Est. Completion 2018-10-29
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02326363 record still lists

NCT02326363 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness Based Relapse Prevention (MBRP) is the first listed.

NCT02326363 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02326363 about?

NCT02326363 is a clinical study titled "Mindfulness-Based Recovery in Veterans". This study will provide important information concerning the used of mindfulness-based relapse prevention (MBRP) as a continuing care strategy for Veterans who have completed primary treatment for a SUD. Most research is focused on the acute care of SUDs, but the risk of relapse to substance use is ...

What is the current status of trial NCT02326363?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2015-03-16. Estimated completion is 2018-10-29.

What interventions are being tested in trial NCT02326363?

The interventions under investigation include: Mindfulness Based Relapse Prevention (MBRP) (BEHAVIORAL), Twelve-Step Facilitation Intervention (TSF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02326363?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02326363's enrollment target sits among peer trials

204 500th of 2000 higher than 1,497 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT04793776 · 204 participants · NA

    Manage Emotions to Reduce Aggression (MERA)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02326363, the US trial registry maintained by the National Library of Medicine. NCT02326363 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.